334 related articles for article (PubMed ID: 34066495)
1. Epigenetic-Based Therapy-A Prospective Chance for Medulloblastoma Patients' Recovery.
Strejczek A; Woszczyk D; Urbaniak H; Różańska M; Robak M; Matuszewska Z; Barciszewska AM
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34066495
[TBL] [Abstract][Full Text] [Related]
2. SnapShot: Medulloblastoma.
Rusert JM; Wu X; Eberhart CG; Taylor MD; Wechsler-Reya RJ
Cancer Cell; 2014 Dec; 26(6):940-940.e1. PubMed ID: 25490452
[TBL] [Abstract][Full Text] [Related]
3. Medulloblastoma epigenetics and the path to clinical innovation.
Haltom AR; Toll SA; Cheng D; Maegawa S; Gopalakrishnan V; Khatua S
J Neurooncol; 2020 Oct; 150(1):35-46. PubMed ID: 32816225
[TBL] [Abstract][Full Text] [Related]
4. Redefining the molecular substructure of medulloblastoma.
Benmaamar R
Lancet Oncol; 2017 Sep; 18(9):e514. PubMed ID: 28757377
[No Abstract] [Full Text] [Related]
5. The long noncoding RNA linc-NeD125 controls the expression of medulloblastoma driver genes by microRNA sponge activity.
Laneve P; Po A; Favia A; Legnini I; Alfano V; Rea J; Di Carlo V; Bevilacqua V; Miele E; Mastronuzzi A; Carai A; Locatelli F; Bozzoni I; Ferretti E; Caffarelli E
Oncotarget; 2017 May; 8(19):31003-31015. PubMed ID: 28415684
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA CCAT1 promotes cell proliferation and metastasis in human medulloblastoma via MAPK pathway.
Gao R; Zhang R; Zhang C; Zhao L; Zhang Y
Tumori; 2018; 104(1):43-50. PubMed ID: 28777430
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic age acceleration among survivors of pediatric medulloblastoma and primitive neuroectodermal tumor.
Harris RD; Richard MA; Gramatges MMJ; Wilhelm K; Scheurer ME; Lupo PJ; Brown AL
Pediatr Hematol Oncol; 2023 May; 40(4):407-411. PubMed ID: 35862575
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA profiling of pediatric Medulloblastoma.
Kesherwani V; Shukla M; Coulter DW; Sharp JG; Joshi SS; Chaturvedi NK
BMC Med Genomics; 2020 Jun; 13(1):87. PubMed ID: 32591022
[TBL] [Abstract][Full Text] [Related]
9. The role of microRNAs in medulloblastoma.
Vidal DO; Marques MM; Lopes LF; Reis RM
Pediatr Hematol Oncol; 2013 Aug; 30(5):367-78. PubMed ID: 23528184
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological features of medulloblastoma: an overview with an emphasis on molecular biology.
de Haas TG; Kool M
Clin Neuropathol; 2007; 26(3):93-110. PubMed ID: 19157001
[TBL] [Abstract][Full Text] [Related]
11. Matching mice to malignancy: molecular subgroups and models of medulloblastoma.
Lau J; Schmidt C; Markant SL; Taylor MD; Wechsler-Reya RJ; Weiss WA
Childs Nerv Syst; 2012 Apr; 28(4):521-32. PubMed ID: 22315164
[TBL] [Abstract][Full Text] [Related]
12. PLK1-associated microRNAs are correlated with pediatric medulloblastoma prognosis.
Pezuk JA; Brassesco MS; de Oliveira RS; Machado HR; Neder L; Scrideli CA; Tone LG
Childs Nerv Syst; 2017 Apr; 33(4):609-615. PubMed ID: 28283778
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic Drivers in Pediatric Medulloblastoma.
Roussel MF; Stripay JL
Cerebellum; 2018 Feb; 17(1):28-36. PubMed ID: 29178021
[TBL] [Abstract][Full Text] [Related]
14. [miR-449a is a potential epigenetic biomarker for WNT subtype of medulloblastoma].
Li YX; Shao LW; Jiang T; Liu Y; Chang Q
Zhonghua Bing Li Xue Za Zhi; 2017 Oct; 46(10):684-689. PubMed ID: 29050069
[No Abstract] [Full Text] [Related]
15. New Approaches in Targeted Therapy for Medulloblastoma in Children.
Maier H; Dalianis T; Kostopoulou ON
Anticancer Res; 2021 Apr; 41(4):1715-1726. PubMed ID: 33813375
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic regulation in medulloblastoma pathogenesis revealed by genetically engineered mouse models.
Shiraishi R; Kawauchi D
Cancer Sci; 2021 Aug; 112(8):2948-2957. PubMed ID: 34050694
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic regulation in medulloblastoma.
Yi J; Wu J
Mol Cell Neurosci; 2018 Mar; 87():65-76. PubMed ID: 29269116
[TBL] [Abstract][Full Text] [Related]
18. Cerebellum development and medulloblastoma.
Roussel MF; Hatten ME
Curr Top Dev Biol; 2011; 94():235-82. PubMed ID: 21295689
[TBL] [Abstract][Full Text] [Related]
19. Medulloblastoma: tumorigenesis, current clinical paradigm, and efforts to improve risk stratification.
Polkinghorn WR; Tarbell NJ
Nat Clin Pract Oncol; 2007 May; 4(5):295-304. PubMed ID: 17464337
[TBL] [Abstract][Full Text] [Related]
20. HIF1A is Overexpressed in Medulloblastoma and its Inhibition Reduces Proliferation and Increases EPAS1 and ATG16L1 Methylation.
Cruzeiro GAV; Dos Reis MB; Silveira VS; Lira RCP; Carlotti CG; Neder L; Oliveira RS; Yunes JA; Brandalise SR; Aguiar S; Eterovic AK; Tone LG; Scrideli CA; Valera ET
Curr Cancer Drug Targets; 2018; 18(3):287-294. PubMed ID: 28302031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]